Sera Prognostics financials
$2.01−0.49%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY25 Dec 31 | FY24 Dec 31 | FY23 Dec 31 | FY22 Dec 31 | FY21 Dec 31 |
|---|---|---|---|---|---|
| Revenue | $81.0K | $77.0K | $306.0K | $268.0K | $82.0K |
| Gross profit | -$83.0K | -$5.0K | $96.0K | $75.0K | $45.0K |
| Gross margin | −102.5% | −6.5% | 31.4% | 28.0% | 54.9% |
| Operating income | -$36.5M | -$36.6M | -$39.8M | -$45.7M | -$35.4M |
| Net income | -$31.9M | -$32.9M | -$36.2M | -$44.2M | -$35.0M |
| Net margin | −39417.3% | −42724.7% | −11843.8% | −16487.3% | −42693.9% |
| Diluted EPS | $-0.67 | $-0.99 | $-1.16 | $-1.43 | $-2.33 |
| EBITDA | -$35.6M | -$35.8M | -$38.9M | -$44.4M | -$34.7M |
| Operating cash flow | -$25.6M | -$14.2M | -$27.2M | -$34.6M | -$31.6M |
| Free cash flow | -$26.3M | -$14.2M | -$27.3M | -$35.4M | -$32.9M |
| Diluted shares | 47.7M | 33.2M | 31.2M | 30.9M | 15.0M |
Balance sheet
| Period end | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|
| Cash & equivalents | $3.9M | $4.0M | $3.9M | $29.9M | $58.9M |
| Short-term investments | $35.3M | $42.2M | $45.2M | $52.8M | $46.2M |
| Total debt | $2.0K | $196.0K | $636.0K | $1.1M | $128.0K |
| Total assets | $101.9M | $72.6M | $95.4M | $116.3M | $147.0M |
| Total liabilities | $26.5M | $24.8M | $25.3M | $17.4M | $8.5M |
| Shareholders' equity | $75.4M | $47.8M | $70.2M | $98.9M | $138.6M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology